Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.868 AED | -.--% | -2.69% | +12.87% |
May. 15 | Julphar Resumes Trading on Abu Dhabi Bourse | MT |
May. 15 | Gulf Pharmaceutical Industries Turns to Q1 Profit; Revenue Tumbles | MT |
Sales 2024 * | 1.69B 461M | Sales 2025 * | 1.8B 490M | Capitalization | 1B 273M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.05 x |
Net Debt 2024 * | 780M 212M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.56 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 2,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 30.76% |
1 week | -2.69% | ||
1 month | -7.76% | ||
3 months | -13.20% | ||
6 months | +15.89% | ||
Current year | +12.87% |
Managers | Title | Age | Since |
---|---|---|---|
Basel Ziyadeh
CEO | Chief Executive Officer | - | - |
Ignacio Anglada
DFI | Director of Finance/CFO | - | - |
Malik Metahri
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rabih Khouri
BRD | Director/Board Member | - | 21-07-31 |
Director/Board Member | - | 16-12-31 | |
Jean Diab
BRD | Director/Board Member | - | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.868 | -.--% | 1,431,956 |
24-05-30 | 0.868 | -.--% | 210,011 |
24-05-29 | 0.868 | -1.36% | 444,035 |
24-05-28 | 0.88 | -1.23% | 248,680 |
24-05-27 | 0.891 | -0.11% | 147,310 |
Delayed Quote Abu Dhabi Securities Exchange, May 31, 2024 at 06:59 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.87% | 273M | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |
- Stock Market
- Equities
- JULPHAR Stock